Cannabis Law Report

NOVEMBER 22, 2019

MMJ International Holdings, the premier medical cannabis research company, announced that it has received DEA approval to ship THC and CBD from Canada. MMJ International Holdings is developing oral drug products from natural whole plant extract derivatives from the marijuana plant containing THC and CBD.

DEA 66

DEA Clinical Trials THC Research and Development 66

Cannabis Law Report

MAY 29, 2022

Earlier this month, Senators Brian Schatz (D-HI) and Cory Booker (D-NJ) sent a letter to the National Institutes of Health (NIH) and the Food and Drug Administration (FDA) urging both agencies to advance research on the therapeutic effects of psychedelic drugs. [1] Recent Regulatory Developments. Challenges.

Research and Development 52

Research and Development DEA Clinical Trials Therapy 52

Cannabis Law Report

FEBRUARY 28, 2022

In the past two decades, pioneering research has rekindled interest in the therapeutic use of psychedelic substances such as psilocybin, ibogaine, and dimethyltryptamine (DMT). Indigenous communities have used them for centuries, and researchers studied them in the 1950s and ‘60s. Glenn Cohen & Mason Marks. 20 February 2022.

Research and Development 52

Research and Development Therapy Law Clinical Trials 52

NORML

MARCH 1, 2019

Currently, the sole federally licensed producer of cannabis for clinical research is the University of Mississippi. ” The agency said that the policy change was necessary because the existing system provided “no clear legal pathway for commercial enterprises to produce marijuana for product development.”

DEA 168

DEA Research and Development Clinical Trials Marijuana 168

Cannabis Law Report

DECEMBER 15, 2021

Benjamin Manufacturing Company to provide cultivation and processing facilities for psilocybin-containing mushrooms for authorized research purposes. market for research purposes is absolutely key for us as we look to expand our business in 2022,” he adds. “With their track-record of working with the U.S.

Supply Chain 52

Supply Chain Research and Development DEA Pharmaceutical 52

Cannabis Law Report

JANUARY 10, 2022

Panacea”), a leading United States biotechnology company focused on developing new therapeutic, cultivation, extraction and isolation techniques for high value natural products such as psychedelic-containing lifeforms and cannabis. is a Canadian biotechnology company providing cannabis testing and research services.

Research and Development 52

Research and Development Supply Chain DEA Events 52

The Blunt Truth

SEPTEMBER 10, 2021

The DEA would like to increase the production quota for marijuana used for research. Under a new state law, lounges allowing consumption of cannabis should be up and running next year. The state’s tourists currently have no place to consume their marijuana purchases, as public consumption is against the law. and finally.

Research and Development 124

Research and Development DEA Consumption State Laws 124

SpeedWeed

MARCH 21, 2021

Trulieve offers Delta-8 in its TruPod vaporizer cartridges and TruClear Syringes, says Beau Williamson, Trulieve director of research and development. Delta-8 is psychoactive, Russo says, though he adds that more research is needed to better understand its effect on humans. That is totally wrong.”. RELATED: U.S.

Research and Development 52

Research and Development Hydroponic DEA Cannabinoids 52

Cannabis Law Report

JULY 9, 2021

The state of the law on psychedelic substances is in flux. Further, numerous private companies have begun to research psychedelic therapy and develop new pharmaceutical compounds derived from psychedelic substances. Some of the most promising substances, and the law applicable to each, are outlined below: Psilocybin.

Law 105

Law Therapy Clinical Trials Research and Development 105

Canna Law Blog

JULY 24, 2020

On Tuesday, July 21, the Food and Drug Administration (“FDA”) released draft guidance for clinical research related to the development and manufacturing of cannabis-based drugs, which gained particular interest following the legalization of hemp in December 2018. tablet or capsule). appeared first on Harris Bricken.

CBD 92

CBD Research and Development DEA Concentrates 92

Cannabis Law Report

JUNE 29, 2021

PUBLISHER: CANNABIS LAW REPORT. In recent months, the DEA has issued a select number of licenses to several groups in the US to allow for the cultivation of Cannabis for scientific research purposes. Segra International completes first export of Cannabis plantlets from Canada to the USA. Photo credit: Dreamstime/TNS).

Research and Development 102

Research and Development DEA Supply Chain Pharmaceutical 102

Cannabis Law Report

JULY 27, 2021

The initiative is part of Project Change Lives; Clever Leaves’ $25M product pledge to aid cannabis research in the U.S. The collaboration represents the Company’s first funded study with a research institution in the United States. organization to help advance scientific research into the potential medical benefits of cannabinoids.

Research and Development 98

Research and Development Pharmaceutical Sativa Extraction 98

Cannabis Law Report

MARCH 18, 2022

Husch Blackwell has launched its Psychedelics and Emerging Therapie s team, an interdisciplinary, cross-office group of lawyers capable of addressing the challenges faced by innovators that seek to research, develop and commercialize novel therapies based on psychedelic drugs. Steve Levine.

Therapy 52

Therapy Research and Development Clinical Trials Environment 52

Veriheal

DECEMBER 27, 2022

Let’s dive into what the research says about these promising new findings and how they might advance the field of psychedelic research. Some research suggests that these substances could be used to treat mental health conditions like depression and anxiety. The subjective nature of self-reported data can plague research.

Research and Development 97

Research and Development Therapy Consumption DEA 97

Canna Law Blog

JULY 17, 2020

A: Most cannabis research applications are ignored, or swatted away after being ignored and litigated and ignored some more. This is being done in violation of international law and the quality is famously poor, in any case (it’s more like hemp). The idea here it to research psilocybin and develop a drug and bring it to market.

DEA 84

DEA Research and Development Therapy Banking 84

Cannabis Law Report

JULY 6, 2021

The Congressional Research Service (CRS) released a report which says there are “three leading markets for hemp, each based on the part of the plant used: fiber, seed/grain, and flower.” The FDA has jurisdiction over the area and hasn’t developed rules allowing for CBD products in the food supply. Marijuana Moment.

Hemp 105

Hemp CBD DEA Legalization 105

Cannabis Law Report

FEBRUARY 10, 2022

Court of Appeals for the Ninth Circuit dismissed a petition for review of a Drug Enforcement Administration (DEA) response to an attorney’s letter seeking advice and guidance on how a physician could administer psilocybin to a terminally ill patient without incurring liability under the Controlled Substances Act (CSA). By Allison Campbell.

DEA 52

DEA Clinical Trials Policy Research and Development 52

CannaMD

AUGUST 8, 2020

Researchers believe cannabis contains over 100 unique chemical compounds! Drugs, substances, and certain chemicals used to make drugs are classified into five categories (known as schedules ) depending on the Department of Drug Enforcement Agency (DEA)’s definition of the drug’s acceptable medical use and abuse/dependency potential.

CBD 100

CBD DEA Research and Development Hemp 100

Cannabis Law Report

JULY 23, 2021

Today, adult use of cannabis, which is classified as a Schedule 1 controlled substance under the Controlled Substances Act (CSA), is legal in 18 states, and the medical use of cannabis is legal in 37 states, though cannabis use remains illegal under federal law. Decriminalization of Cannabis, Recognition of State law Controlling Cannabis.

Research and Development 105

Research and Development DEA Programs State Laws 105

Cannabis Law Report

AUGUST 18, 2022

The firm’s deep expertise in pharmaceutical sciences, FDA regulatory compliance and pharmaceutical product liability litigation and risk management enables it to address complex legal hurdles faced by stakeholders seeking to research, develop, invest in and bring-to-market psychedelic therapies. BUFFALO, N.Y. , Aug. Tweet this.

Therapy 52

Therapy Research and Development Pharmaceutical Treatment 52

United Patients Group

APRIL 3, 2023

Although both are legal under state law, there are currently 29 states with legislation allowing for medical cannabis and the District of Columbia. Epidiolex, an FDA-approved medication containing CBD (cannabidiol), has been listed as Schedule 5 by the DEA since June 25th, 2019.

DEA 52

DEA Patients Conditions Cannabis 52

Cannabis Law Report

AUGUST 18, 2022

Hemp supply chain companies need qualified third-party laboratories that meticulously follow nuanced laws to ensure their products are permissible across the country. With that research, they created elaborate matrices to compare each mandate. End-users also deserve the safest, highest quality products–regardless of where they reside.

Compliance 52

Compliance Compliance Hemp Research and Development 52

Canna Law Blog

OCTOBER 27, 2020

We are on record here at the law firm in support of Measure 109. It’s going to take a couple of years for the first of these to roll out, and we should have even more scientific research and public acceptance for the medical applications of psilocybin by then. The Oregon program will not square with federal laws.

DEA 79

DEA Decriminalization Research and Development Programs 79

Veriheal

AUGUST 24, 2022

Now, a psychedelic-focused bill aimed at reforming laws surrounding psychedelics further in the state has successfully qualified for the November ballot. Research and Testimonials Point to Psychedelics’ Therapeutic Benefits. The city of Denver, Colorado, decriminalized the possession and use of psilocybin in 2019—the first U.S.

Legalization 109

Legalization Decriminalization Medicine Research and Development 109

Canna Law Blog

AUGUST 7, 2023

Today, every time I research these new cannabinoids, I inevitably see ones I have never heard of before. What I generally say is that in most cases, there will be no federal or state law that specifically deals with that cannabinoid. And it is not on the CSA (the DEA tried and then backed off efforts to schedule it in 2016).

Cannabinoids 76

Cannabinoids Food DEA CBD 76

Cannabis Law Report

APRIL 21, 2022

MAPS and MAPS PBC have developed the first validated commercial synthetic process for producing multi-kilogram batches of MDMA under current Good Manufacturing Practices. The full statement. Nair, Ph.D., lead author and MAPS PBC Head of Chemistry, Manufacturing, and Controls. Berra Yazar-Klosinski, Ph.D.

Clinical Trials 52

Clinical Trials Research and Development Therapy Media 52

Cannabis Law Report

OCTOBER 5, 2021

“This shows that combination of psilocybin and music has a strong emotional effect, and we believe that this will be important for the therapeutic application of psychedelics if they are approved for clinical use,” said lead researcher Dea Siggaard Stenbæk , Associate Professor University of Copenhagen.

Clinical Trials 52

Clinical Trials Research and Development DEA Therapy 52

SpeedWeed

MARCH 21, 2021

Trulieve offers Delta-8 in its TruPod vaporizer cartridges and TruClear Syringes, says Beau Williamson, Trulieve director of research and development. Delta-8 is psychoactive, Russo says, though he adds that more research is needed to better understand its effect on humans. That is totally wrong.”. RELATED: U.S.

THC 52

THC Business DEA Cannabinoids 52

SpeedWeed

MARCH 17, 2021

Trulieve offers Delta-8 in its TruPod vaporizer cartridges and TruClear Syringes, says Beau Williamson, Trulieve director of research and development. Delta-8 is psychoactive, Russo says, though he adds that more research is needed to better understand its effect on humans. That is totally wrong.”. RELATED: U.S.

DEA 52

DEA Cannabinoids Research and Development THC 52

Cannabis Law Report

JANUARY 11, 2019

federal law protects the retail sale of hemp-derived CBD. . Our analysis follows: Hemp-derived CBD is no longer a controlled substance under federal law. The FDA’s position on CBD is unsettled and unsupported by law. While the DEA is now officially out of the hemp regulation business, the U.S.

Hemp 49

Hemp CBD Law Seed-To-Sale 49

Cannabis Law Report

OCTOBER 31, 2019

The first crisis point initiated by the Rule is its requirement that Labs “ must be registered by the DEA to conduct chemical analysis of controlled substances (in accordance with 21 CFR 1301.13). ” The USDA helpfully indicates that it will post directions for obtaining a DEA registration. Will that disqualify Labs in those states?

Hemp 45

Hemp DEA Concentrates THC 45

Cannabis Law Report

AUGUST 12, 2022

Drug policy topics have become a consistent feature of the Austin-based event in recent years as more states have legalized cannabis and moved to reform laws around psychedelics like psilocybin locally and at the state level. Obtaining DEA License to Grow Psilocybin Mushrooms. Here are some psychedelics panel options: .

Research and Development 52

Research and Development Events Topical Policy 52

Veriheal

AUGUST 31, 2020

We are humbled to introduce you to them and their exceptional ideas, ranging from community grassroots mental health efforts designed to empower historically vulnerable communities of color, to research plans for identifying strain specific genetics. Veriheal’s Innovation in Cannabis Scholarship 2020 Winners . Nishtha Tripathi.

Research and Development 117

Research and Development Education Agriculture Patients 117

Cannabis Law Report

SEPTEMBER 20, 2019

The sale will greatly reduce the current and future burn rate of the company and allow it to focus on achieving profitability, seeking a DEA license, and implementing GMP, a set of regulations promulgated by the U.S.

Clinical Trials 40

Clinical Trials Research and Development DEA Business 40

Cannabis Law Report

APRIL 1, 2019

Cannabis law legislators must have had the TOAT in mind when they listed government organizations with agricultural research and development capabilities and close relationships with farmer groups as those eligible to apply for the five types of licenses: production, sale, import, export and possession. The law is unclear.

Research and Development 40

Research and Development Pharmaceutical Clinical Trials DEA 40

Cannabis Law Report

JANUARY 23, 2020

This paper shall give a condensed overview over the status quo in Thailand and the potential emerging from the ongoing developments.” This paper shall give a condensed overview over the status quo in Thailand and the potential emerging from the ongoing developments. $16. It can be downloaded at: [link]. cannabis programm. $4b.

Research and Development 59

Research and Development Oil Cultivation DEA 59

Cannabis Law Report

JANUARY 30, 2019

For nearly fifty years, the University of Mississippi has had the sole contract with the National Institute on Drug Abuse (NIDA) to grow cannabis for research purposes. Do you intend to support the expansion of marijuana manufacturers for scientific research? R ESPONSE: Yes. RESPONSE: I have not studied this issue closely. Hearing Tr.

Research and Development 63

Research and Development DEA CBD Law 63